Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Link to SEPIO compliant JSON-LD document

Variant: NM_000545.8(HNF1A):c.335C>T (p.Pro112Leu)

CA124475

14942 (ClinVar)

Gene: HNF1A

Condition: monogenic diabetes

Inheritance Mode: Autosomal dominant inheritance

Link to MONDO

UUID: 53a9fce0-d78f-477d-9a67-dfcbda28884c

HGVS expressions

NM_000545.8:c.335C>T

NM_000545.8(HNF1A):c.335C>T (p.Pro112Leu)

NC_000012.12:g.120988841C>T

CM000674.2:g.120988841C>T

NC_000012.11:g.121426644C>T

CM000674.1:g.121426644C>T

NC_000012.10:g.119911027C>T

NG_011731.2:g.15096C>T

ENST00000257555.11:c.335C>T

ENST00000257555.10:c.335C>T

ENST00000400024.6:c.335C>T

ENST00000402929.5:n.470C>T

ENST00000535955.5:n.43-8650C>T

ENST00000538626.2:n.191-8650C>T

ENST00000538646.5:c.335C>T

ENST00000540108.1:c.327-4679C>T

ENST00000541395.5:c.335C>T

ENST00000541924.5:c.335C>T

ENST00000543427.5:c.335C>T

ENST00000544413.2:c.335C>T

ENST00000544574.5:c.73-7776C>T

ENST00000560968.5:n.478C>T

ENST00000615446.4:c.-257-7421C>T

ENST00000617366.4:c.335C>T

NM_000545.5:c.335C>T

NM_000545.6:c.335C>T

NM_001306179.1:c.335C>T

NM_001306179.2:c.335C>T

Pathogenic

PM2_Supporting PS4_Moderate PS3 PP3 PP4_Moderate PP1_Strong PM1

Evidence Links 0

Expert Panel

Monogenic Diabetes VCEP

Criteria Specification Information

Criteria Specification: ClinGen Monogenic Diabetes Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 1.1

PDF

Criteria Specification Approval History

Criteria Specifications for this VCEP

Evidence submitted by expert panel

Monogenic Diabetes VCEP

The c.335C>T variant in the HNF1 homeobox A gene, HNF1A, causes an amino acid change of proline to leucine at codon 112 (p.(Pro112Leu)) of NM_000545.8. This variant is predicted to be deleterious by computational evidence, with a REVEL score of 0.966, which is greater than the MDEP VCEP threshold of 0.70 (PP3) and is absent from gnomAD v2.1.1 (PM2_Supporting). Additionally, this variant is located within a conserved region of the DNA binding domain (codons 107-174 and 201-280) of HNF1A, which is defined as critical for the protein’s function by the ClinGen MDEP (PM1_Supporting). This variant was identified in six unrelated individuals with non- autoimmune and non-absolute/near-absolute insulin-deficient diabetes (PS4_Moderate; internal lab contributors). This variant was identified in two individuals with a clinical history highly specific for HNF1A-MODY (MODY probability calculator result >50%, negative genetic testing for HNF4A, and response to low dose sulfonylureas) (PP4_Moderate; internal lab contributors). A luciferase assay meeting the ClinGen MDEP quality control specifications demonstrated that the p.Pro112Leu protein has transactivation activity below 40% of wildtype, indicating that this variant impacts protein function (PS3_Moderate, PMID: 32910913). Lastly, this variant segregated with diabetes, with 11 informative meioses in six families with MODY (PP1_Strong; internal lab contributors). In summary, c.335C>T meets the criteria to be classified as pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.1, approved 9/30/21): PP3, PM1_Supporting, PM2_Supporting, PP4_Moderate, PS4_Moderate,PS3_Moderate, PP1_Strong.

PM2_Supporting

This variant has a minor allele frequency in gnomAD of less than 0.00002 in the European non-Finnish sub-population (actual value = 0.000008803) and is absent from other gnomAD sub-populations.

PS4_Moderate

This variant was identified in six unrelated individuals with non- autoimmune and non-absolute/near-absolute insulin-deficient diabetes (PS4_Moderate; internal lab contributors).

PS3

Two functional in vitro studies demonstrated that cells with this variant display decreased transactivation and DNA binding (both <40% compared to wild type), but do retain normal cellular localization (PMIDs: 27899486 and 12574234).

PP3

REVEL 0.966+ FATHMM, LRT, MetaLR, MetaSVM, MutationTaster, PROVEAN and SIFT all predict deleterious; MutationAssessor said Medium, GERP score 5.08

PP4_Moderate

This variant was identified in two individuals with a clinical history highly significant HNF1A-MODY (MODY probability calculator result >50% and negative genetic testing for HNF4A), who also responded to low dose sulfonylureas.

PP1_Strong

This variant segregated with disease in 11 informative meioses in six families with MODY (internal lab contributors).

PM1

This variant is located within a conserved region of the DNA binding domain (codons 107-174 and 201-280 of HNF1A), which is defined as critical for the protein’s function by the ClinGen MDEP/

Approved on: 2022-04-08

Published on: 2022-07-12

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.